The Biotech Booster Acceleration Program organized by Business France encourages the international development of French innovations in healthcare to improve the patient’s access to disrupting new therapies.
Biotech Booster is a 3-step startup acceleration program for French companies in the field of Biotechnologies willing to develop in North America.
2000 +
French companies in healthtech, 42% of which are in biotech
1
in 5 companies has at least one subsidiary abroad
131
healthtech companies listed on the Euronext markets in Europe, including 75 French companies, representing a total stock market listing of nearly €60 billion.
32
% of French healthtech partnerships are with international players
Agenda
1st step – SELECTION (April 2022| Virtual)
- Pitch and Q&A session in front of a panel of North American experts including Biotech, Big Pharma, Centers of Excellence/Hospitals & Investors.
- Experts & Mentors: a jury of North American experts will select the companies participating to steps 2 & 3 of the program. These experts will support the delegation throughout the program.
- Laureates awards day (Paris): evening bringing together the French Biotech ecosystems with the presence of North Americans stakeholders.
2nd step – BOOTCAMP – WORKSHOPS (June 2022 | Virtual)
- Workshops: learning sessions with North American experts regarding Pitch & Positioning, Regulatory & FDA, Market Access, Marketing & Communication, Fund Raising, Negotiation and Implantation.
- Coaching & Personalized 1:1 sessions with the aim to refine the participants’North-American strategy, as well as their product & solution presentations. They will be supported by regulatory, market access and communication experts.
- Feedback Meetings: pitch training during 1:1 meetings with Centers of Excellence/Hospitals Big Pharma & Investors.
3rd step – ROADSHOW (September 2022 | Boston & Montreal)
- Business meetings to present the participants’ innovation to the North American market during B2B meetings with potential targeted clients, partners, decision-makers and KOLs from Biotech, Big Pharma, Centers of Excellence/Hospitals & Investors.
- Network & Pitch opportunity to gain visibility during events networking, pitch contests.
- Visits & Meetings todiscover major U.S. and Canadian stakeholders
2022 Selection Committee
The North American Selection Committee (USA & Canada) evaluates French startups during Pitch Session and selects the companies that will participate to the next steps (Bootcamp Workshops & Business Roadshow).
These experts also support companies and play a key role during the program.
Jury Members
- Gabriela APIOU – Director Strategic Alliances at Massachusetts General Hospital Research Institute
- Katie BODNER – Associate at 5AM Ventures
- Khadija ELABID BASHLLARI – Senior Manager, Program and Alliance Management at Moderna
- Kareem REDA – Chief Business Officer at ElevateBio
- Brock REEVE – Executive Director at Harvard Stem Cell Institute
- Julie YANG – VP at Bain Capital Life Sciences